CirChem AB (CIRCHE) fair value: what the stock is really worth
As of Oct 13, 2026: fair value of CirChem AB SEK 0.74, price SEK 0.53, upside +38.6%, quality 17 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range kr 0.5000 – kr 15.12 · fair‑value band kr 0.5500 – kr 1.10 · the kr 0.5340 price screens below the kr 0.7400 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow CirChem in your weekly email
Every Wednesday you see whether CirChem is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
CirChem AB (publ), an environmental technology company, engages in the solvent recycling business in Sweden. It collects, filters, and purifies industrial solvents for reuse. The company is also involved in the production of chemical products, such as washer fluids and hand sanitizers.
Show more
CirChem AB (publ), an environmental technology company, engages in the solvent recycling business in Sweden. It collects, filters, and purifies industrial solvents for reuse. The company is also involved in the production of chemical products, such as washer fluids and hand sanitizers. CirChem AB (publ) was incorporated in 2013 and is headquartered in Vargön, Sweden.
Stock analysis
CirChem AB (CIRCHE) currently trades at kr 0.5340, while our model-based Fair Value estimate is kr 0.7400, implying the stock looks roughly 27.8% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.
Scenario range: kr 0.5500 (bear) to kr 1.10 (bull), the price of kr 0.5340 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 17/100 (below-average quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
CirChem AB reported revenue of 10.0M SEK in FY2025 versus 85.6K SEK in FY2021, a compound +228.5%/yr. Reported net income was −12.1M SEK in FY2025.
Key figures
Market cap 21.5M SEK (≈ $2.1M) · P/S ratio 2.69 · EPS (TTM) kr −0.4500 · Net margin −121% · Return on equity −36.6% · Return on assets (EBIT) −22.9% · Operating margin −217% · Revenue (TTM) 7.5M SEK.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 39 out of 100 (low confidence).
What moves the price
The share trades about 66% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −19% fair-value upside, at 39%, CIRCHE screens cheaper than that median.
Fair Value models
Bear kr 0.5500Fair Value kr 0.7400Bull kr 1.10
Price kr 0.5340 · Upside +38.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.23/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−51.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+156.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+167.1%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+79.2%
’18
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−12,204.1% (2020) → −112.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Waste Management · 152 stocks
Beats the industry median on 4/8 measures
A mixed picture versus its industry peers.
Valuation
Quality Score17 · Bottom 25%
Fair Value upside+40.7% · Above median
Profitability
Return on assets−15.2% · Bottom 25%
Net margin (TTM)−121.0% · Bottom 25%
Growth and dividend
Revenue growth−21.5% · Bottom 25%
Balance sheet
Debt / equity0.29× · Below median
Valuation Multiplesvs Waste Management median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "CirChem AB Fair Value". https://www.fairvalue-calculator.com/stock/CIRCHE
Frequently asked questions
Is CirChem AB (CIRCHE) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of kr 0.7400 versus a price of kr 0.5340, about +39% upside (undervalued).
What is the fair value of CIRCHE?
Our model-based fair value for CirChem AB is kr 0.7400 (as of Oct 3, 2026), built from audited fundamentals. The current price: kr 0.5340.
What is the quality score of CIRCHE?
CirChem AB has a Quality Score of 17/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CirChem AB (CIRCHE)?
Our model-based price target is the fair value of kr 0.7400 (as of Oct 3, 2026) from 1 valuation models. Cautious scenario kr 0.5500, optimistic scenario kr 1.10. It is a calculation from audited fundamentals, not an analyst target.
What is the CirChem AB stock forecast for 2026?
Our models put fair value at kr 0.7400, about +39% upside versus a price of kr 0.5340 (undervalued). Cautious scenario kr 0.5500, optimistic scenario kr 1.10. The calculation is refreshed regularly with new filings.
What is the revenue of CirChem AB (CIRCHE)?
CirChem AB reported trailing-twelve-month revenue of about 7.5M SEK (latest available figure, as of Oct 3, 2026).
What is the intrinsic value of CirChem AB (CIRCHE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CirChem AB it is kr 0.7400 per share (as of Oct 3, 2026), against a price of kr 0.5340. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is CirChem AB stock overvalued or undervalued in 2026?
As of Oct 3, 2026, CIRCHE trades below its calculated fair value: price kr 0.5340, fair value kr 0.7400, a gap of about +39% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CIRCHE?
No. The price is what the market pays today (kr 0.5340); the fair value is what the company's own numbers justify (kr 0.7400). For CirChem AB the two are kr 0.2060 per share apart. That gap is exactly why we show both numbers side by side.
How much is CirChem AB worth?
The market values CirChem AB at about 21.5M SEK (market capitalisation, as of Oct 3, 2026). Per share that is kr 0.5340; our models calculate a fair value of kr 0.7400 per share.
What do the bullish and bearish scenarios say about CIRCHE?
Our models span a range for CirChem AB: cautious scenario kr 0.5500, base kr 0.7400, optimistic kr 1.10 per share (as of Oct 3, 2026, price kr 0.5340). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of CirChem AB (CIRCHE)?
Balance-sheet figures for CirChem AB (as of Oct 3, 2026): return on equity −36.6%, debt of 0.29 per unit of equity. They feed the Quality Score of 17/100, which measures business quality independently of the share price.
How far is CIRCHE from its 52-week high?
CirChem AB trades at kr 0.5340, about 66% below its 52-week high of kr 1.59 and 7% above the low of kr 0.5000 (as of Oct 13, 2026). Distance from the high says nothing about value: that is what the fair value of kr 0.7400 is for.
Which stocks are comparable to CirChem AB?
From the same area (Industrials) we also value Waste Management, Inc, Republic Services, Inc, Waste Connections, Inc, Veolia Environnement SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CirChem AB stock attractive at the current price?
The data as of Oct 3, 2026: price kr 0.5340, calculated fair value kr 0.7400 (+39%), Quality Score 17/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CIRCHE calculated?
We run CirChem AB through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of kr 0.7400, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.8 % above its aggregate fair value. CirChem AB currently trades 28 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CirChem AB (CIRCHE)?
The closing price on Oct 13, 2026 was kr 0.5340. Our model-based fair value is kr 0.7400, about +39% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CirChem AB right now?
The large discount to fair value meets weak quality (17/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (kr 0.5500). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range (kr 0.5500 to kr 1.10) leaves room in how you read the outcome.
Key figures of CirChem AB
How large is the market capitalisation of CirChem AB (CIRCHE)?
The market capitalisation of CirChem AB is 21.5M SEK (≈ $2.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CirChem AB (CIRCHE)?
The price-to-sales ratio of CirChem AB is 2.69 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of CirChem AB (CIRCHE)?
Earnings per share at CirChem AB are kr −0.4500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of CirChem AB (CIRCHE)?
The net margin of CirChem AB is −121% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CirChem AB (CIRCHE)?
The return on equity (ROE) of CirChem AB is −36.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CirChem AB (CIRCHE)?
On an EBIT basis the return on assets of CirChem AB is −22.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CirChem AB (CIRCHE)?
The operating margin of CirChem AB is −217% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CirChem AB (CIRCHE)?
Revenue at CirChem AB is growing −21.5% versus a year earlier (3y avg +156%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does CirChem AB (CIRCHE) generate?
The free cash flow of CirChem AB is −20.6M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does CirChem AB (CIRCHE) hold?
CirChem AB holds more cash than debt, 751K SEK net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch CirChem AB in the live analysis
One click puts CirChem AB on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.
